Sunil Healthcare Reports Mixed Financial Results for Q2 2024, Operating Profit Improves

Nov 14 2024 09:04 PM IST
share
Share Via
Sunil Healthcare, a microcap pharmaceutical company, reported a negative performance in the second quarter of fiscal year 2024-2025. However, the company's operating profit to interest ratio has improved, indicating better management of interest payments. On the other hand, operating cash flow and debtors turnover ratio have been consistently decreasing, while net sales and cash and cash equivalents have also shown a negative trend. Investors should carefully evaluate these factors before investing in the company's stock.

Sunil Healthcare, a microcap pharmaceutical company, recently announced its financial results for the quarter ending September 2024. The company's stock has been given a 'Strong Sell' rating by MarketsMOJO.

According to the financial report, Sunil Healthcare has seen a negative performance in the second quarter of the fiscal year 2024-2025. However, there has been a slight improvement in the company's score, which has gone from -7 to -6 in the last three months.

One of the positive aspects of Sunil Healthcare's financials is its operating profit to interest ratio, which is the highest it has been in the last five quarters at 1.55 times. This indicates that the company's ability to manage its interest payments is improving.

On the other hand, there are some areas where Sunil Healthcare needs to work on based on its September 2024 financials. The company's operating cash flow has been consistently falling over the last three years, with the latest figure being at Rs -15.40 crore. Additionally, the debtors turnover ratio has also been decreasing each half year, indicating a slower pace in settling debts.

Furthermore, the company's net sales for the quarter have been the lowest in the last five quarters at Rs 20.26 crore, showing a negative trend in the near term. This figure has also fallen by -9.1% compared to the average net sales of the previous four quarters. Additionally, the cash and cash equivalents for the half year have been at its lowest in the last six periods, indicating a deterioration in short-term liquidity.

Overall, Sunil Healthcare's financial performance for the quarter ending September 2024 has been negative, with some areas showing improvement while others need attention. Investors should carefully consider these factors before making any decisions regarding the company's stock.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Sunil Healthcare falling/rising?
Nov 14 2025 10:06 PM IST
share
Share Via
Is Sunil Healthcare overvalued or undervalued?
Nov 10 2025 08:07 AM IST
share
Share Via
Is Sunil Healthcare overvalued or undervalued?
Nov 09 2025 08:07 AM IST
share
Share Via
Is Sunil Healthcare overvalued or undervalued?
Nov 08 2025 08:06 AM IST
share
Share Via
Are Sunil Healthcare latest results good or bad?
Nov 05 2025 07:13 PM IST
share
Share Via